ECG Q1 2026 Earnings Call Summary | Stock Taper
Logo
ECG

ECG — Everus Construction Group, Inc.

NYSE


Q1 2026 Earnings Call Summary

May 6, 2026

Everus Construction Group, Inc. (ECG) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

  • Revenues: $1.04 billion, a 25% increase year-over-year.
  • EBITDA: $88.9 million, up 44% from Q1 2025, with an EBITDA margin of 8.6%, improving by 110 basis points.
  • Backlog: Record $3.68 billion, a 20% increase from the prior year, with notable growth in both the E and M (Electrical and Mechanical) and T and D (Transmission and Distribution) segments.
  • Operating Cash Flow: $143.7 million, significantly up from $7.1 million in Q1 2025.
  • Free Cash Flow: $131.9 million, compared to a cash use of $8.1 million in the same quarter last year.
  • Pro Forma Net Leverage: Approximately 0.5 times after the acquisition of SCNM.

2. Strategic Updates and Business Highlights

  • Acquisition: Successful acquisition of SCNM, expanding ECG's geographic footprint into the Southeast, particularly in the pharma and healthcare sectors.
  • Market Trends: Strong performance attributed to favorable trends in diverse markets, including data centers, hospitality, and utilities.
  • Operational Excellence: Continued focus on disciplined project selection and execution, maintaining a balanced approach between fixed-price and cost-plus contracts to mitigate risks.

3. Forward Guidance and Outlook

  • 2026 Revenue Guidance: Raised to a range of $4.3 billion to $4.4 billion.
  • EBITDA Guidance: Updated to a range of $345 million to $360 million, implying EBITDA margins around 8.1%.
  • Market Expectations: Anticipation of continued backlog growth and stable margins, with no significant seasonal dips expected throughout the year.

4. Bad News, Challenges, or Points of Concern

  • Labor Availability: Ongoing challenges in securing qualified labor, which could impact scaling and project execution.
  • Conservative Guidance: Some analysts noted that the EBITDA guidance did not reflect the strong backlog and revenue growth, suggesting a cautious approach from management.
  • Market Competition: While competition remains stable, the ability to maintain margins amidst this competition is a concern.

5. Notable Q&A Insights

  • Geographic Expansion: Management expressed optimism about future awards in new geographies, particularly with a high-tech client, indicating potential for additional contracts.
  • Payment Terms: Improved payment terms have positively impacted cash flow, but management cautioned that the strong cash results in Q1 may not be indicative of sustained performance throughout the year.
  • Contract Mix: The preference for maintaining a balance between fixed-price and cost-plus contracts was reiterated, emphasizing risk management and consistent margin improvement.

Overall, ECG reported a strong start to 2026 with record revenues and a robust backlog, while also navigating challenges related to labor availability and market competition. The company remains optimistic about growth opportunities and strategic initiatives moving forward.